Accessibility StatementSkip Navigation NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https: ...

Core Viewpoint - A class action securities lawsuit has been filed against KBR, Inc. alleging securities fraud that affected investors between May 6, 2025, and June 19, 2025 [1][2]. Group 1: Lawsuit Details - The complaint claims that KBR, Inc. made false statements regarding its partnership with HomeSafe, despite knowing that the U.S. Department of Defense had concerns about HomeSafe's ability to fulfill a global household goods contract [2]. - It is alleged that the defendants misrepresented KBR's business operations and prospects, leading to materially false and misleading statements [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 18, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Dow Inc. for alleged securities fraud affecting investors between January 30, 2025, and July 23, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [2]. - It is alleged that the negative impacts of competitive pressures, declining global sales, and product oversupply on Dow's business were understated [2]. - The defendants' public statements are claimed to have been materially false and misleading throughout the relevant period [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Law Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as a leading firm in securities litigation [4]. - The firm has over 70 employees and has been ranked in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against PubMatic, Inc. due to alleged securities fraud affecting investors between February 27, 2025, and August 11, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that PubMatic's management made false statements and concealed critical information regarding a major demand side platform buyer shifting clients to a new platform, leading to a reduction in ad spend and revenue for PubMatic [2]. - The lawsuit claims that the positive statements made by the defendants about PubMatic's business and prospects were materially misleading and lacked a reasonable basis due to the aforementioned issues [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 20, 2025, to request to be appointed as lead plaintiff in the lawsuit [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, highlighting its expertise in complex securities litigation [4].

Core Points - A class action securities lawsuit has been filed against Snap Inc. for alleged securities fraud affecting investors between April 29, 2025, and August 5, 2025 [1][2] - The lawsuit claims that Snap misled investors about its advertising revenue growth, which dropped from 9% in Q1 to only 1% in April 2025 [2] - Following the announcement of disappointing financial results on August 5, 2025, Snap's stock price fell from $9.39 to $7.78, a decline of approximately 17.15% in one day [2] Case Details - The complaint alleges that Snap provided overly positive statements while concealing material adverse facts about its advertising revenue growth [2] - Snap attributed the slowdown in advertising revenue growth to issues with its ad platform, the timing of Ramadan, and minor changes [2] - Investors affected by the decline in stock price have until October 20, 2025, to request to be appointed as lead plaintiff in the lawsuit [3] Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) HaloMD, a third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (iii) in addition, the Company overstated the extent to which it h ...

LFMD investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants materially overstated LifeMD's competitive position; (2) defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition cost ...

Core Points - A class action securities lawsuit has been filed against Fortinet, Inc. for alleged securities fraud affecting investors between November 8, 2024, and August 6, 2025 [1] - The lawsuit claims that Fortinet misrepresented the potential profitability of its product refresh cycle and concealed the true number of FortiGate firewalls eligible for upgrades [2] - Investors have until November 21, 2025, to request to be appointed as lead plaintiff, with no out-of-pocket costs for class members [3] Company Details - Fortinet, Inc. is facing allegations of securities fraud related to misleading statements about its product refresh cycle and the performance of its FortiGate firewalls [2] - The lawsuit highlights that the refresh cycle consisted of older products that represented a "small percentage" of the company's business, contradicting the company's claims [2] Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims centered around undisclosed adverse financial information and misleading guidance during a specific class period [1][4][5]. Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicaid, Medicare, and state insurance marketplaces [3]. Allegations of the Lawsuit - The lawsuit alleges that Molina Healthcare failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. - It is claimed that Molina's near-term growth relied on reduced utilization of various healthcare services, which was not communicated to investors [4]. - The lawsuit also states that Molina's financial guidance for fiscal year 2025 was likely to be significantly reduced due to these undisclosed factors [4]. Financial Performance and Impact - On July 7, 2025, Molina reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - Following this announcement, Molina Healthcare's stock price experienced a decline, attributed to the revelation of ongoing medical cost pressures [5]. - On July 23, 2025, Molina further cut its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and projecting adjusted earnings of no less than $19.00 per diluted share for the full year [6]. - This announcement led to a nearly 17% drop in Molina's stock price, reflecting investor reaction to the challenging medical cost environment [6]. Legal Process - Investors who purchased Molina Healthcare securities during the class period have until December 2, 2025, to seek appointment as lead plaintiff in the class action lawsuit [1][7]. - The lead plaintiff will represent the interests of all class members and can select a law firm to litigate the case [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8][9].

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving F5, Inc., focusing on whether F5 and its executives made false or misleading statements or failed to disclose material information to investors [1] Company Overview - F5, Inc. provides multi-cloud application security and delivery solutions [2] Recent Developments - On October 15, 2025, F5 disclosed that a highly sophisticated nation-state threat actor gained unauthorized access to certain F5 systems, maintaining long-term access to systems including the BIG-IP product development environment and engineering knowledge management platform [3] - F5's investigation revealed that certain files were exfiltrated, including portions of the BIG-IP source code and information about undisclosed vulnerabilities [3] - Following this revelation, the price of F5 shares experienced a decline [3]